BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Beam Global
BEEM
$23.3M
| $11.5M | ﹤0.01% |
561,382
+18,648
| +3% | +$272K |
|
3452
Daktronics
DAKT
$955M
| $11.4M | ﹤0.01% |
2,970,533
+186,636
| +7% | +$857K |
|
|
ERUS
3453
DELISTED
iShares MSCI Russia ETF
ERUS
| $11.4M | ﹤0.01% |
1,408,933
-779,858
| -36% | -$27.9M |
|
3454
Plains GP Holdings
PAGP
$5.21B
| $11.3M | ﹤0.01% |
982,470
-376,975
| -28% | -$4.33M |
|
|
LFACU
3455
DELISTED
LF Capital Acquisition Corp. II Units
LFACU
| $11.3M | ﹤0.01% |
1,125,000
| – | – |
|
3456
Zevra Therapeutics
ZVRA
$562M
| $11.3M | ﹤0.01% |
2,253,334
+17,792
| +0.8% | +$113K |
|
3457
Tango Therapeutics
TNGX
$4.43B
| $11.3M | ﹤0.01% |
1,493,186
+340,746
| +30% | +$2.95M |
|
|
INST
3458
DELISTED
Instructure Holdings, Inc.
INST
| $11.3M | ﹤0.01% |
563,678
-12,586
| -2% | -$273K |
|
3459
Lightspeed Commerce
LSPD
$1.31B
| $11.3M | ﹤0.01% |
370,978
-4,220,662
| -92% | -$126M |
|
|
SHYM
3460
iShares Short Duration High Yield Muni Active ETF
SHYM
$795M
| $11.3M | ﹤0.01% |
475,000
-150,000
| -24% | -$3.75M |
|
|
OZON
3461
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $11.3M | ﹤0.01% |
1,200,004
-4,488,995
| -79% | -$95.1M |
|
3462
CEL-SCI Corp
CVM
$20.3M
| $11.3M | ﹤0.01% |
95,696
-2,378
| -2% | -$387K |
|
3463
Preformed Line Products
PLPC
$1.75B
| $11.3M | ﹤0.01% |
177,742
-5,487
| -3% | -$329K |
|
|
VIEW
3464
DELISTED
View, Inc. Class A Common Stock
VIEW
| $11.2M | ﹤0.01% |
101,398
-42,796
| -30% | -$6.47M |
|
3465
Viemed Healthcare
VMD
$447M
| $11.2M | ﹤0.01% |
2,240,571
+26,045
| +1% | +$121K |
|
3466
Eos Energy Enterprises
EOSE
$1.22B
| $11.2M | ﹤0.01% |
2,668,119
+27,981
| +1% | +$115K |
|
3467
Humacyte
HUMA
$176M
| $11.1M | ﹤0.01% |
1,577,919
+176,846
| +13% | +$1.03M |
|
3468
Rapid Micro Biosystems
RPID
$106M
| $11.1M | ﹤0.01% |
1,636,539
+245,098
| +18% | +$1.8M |
|
3469
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$148M
| $11.1M | ﹤0.01% |
428,981
-32,604
| -7% | -$816K |
|
3470
Lloyds Banking Group
LYG
$89.5B
| $11.1M | ﹤0.01% |
4,595,821
+665,360
| +17% | +$1.77M |
|
|
PSTX
3471
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $11.1M | ﹤0.01% |
2,468,954
-84,036
| -3% | -$379K |
|
|
VLD
3472
DELISTED
Velo3D, Inc.
VLD
| $11M | ﹤0.01% |
33,885
-2,667
| -7% | -$670K |
|
|
HUYA
3473
Huya Inc
HUYA
$563M
| $11M | ﹤0.01% |
2,467,829
+49,340
| +2% | +$283K |
|
|
VIRX
3474
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $11M | ﹤0.01% |
2,312,908
-56,010
| -2% | -$169K |
|
3475
Navitas Semiconductor
NVTS
$2.84B
| $11M | ﹤0.01% |
1,069,215
-7,001
| -0.7% | -$71.8K |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.